was found to induce autophagic cell death in HER2-overexpressing BT-474 breast cancer cells leading to a vacuole formation and increasing levels for autophagy markers (e.g., LC3A/B, ATG3, ATG7, and ATG16L) in human breast cancer cells [40]. This evidence concerns the gene ATG3 and breast carcinoma.